Agios is focused on discovering and developing novel medicines to treat cancer and rare genetic diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across both therapeutic areas. Agios has an approved oncology precision medicine and multiple first-in-class investigational therapies. All Agios programs focus on genetically identified patient populations, leveraging our knowledge of metabolism, biology and genomics.
88 Sidney Street
Cambridge, Massachusetts 02139